Volume 4
Journal of Infectious Diseases and Treatment
ISSN: 2472-1093
Page 51
Euro Infectious Diseases 2018 &
Histopathology 2018
September 27-29, 2018
&
JOINT EVENT
September 27-29, 2018 Rome, Italy
5
th
International Conference on
Histopathology & Cytopathology
10
th
Euro-Global Conference on
Infectious Diseases
Direct evidence of viral infection and mitochondrial alterations in the brain of fetuses at high risk for
schizophrenia
Segundo Mesa Castillo
Havana Psychiatric Hospital, Cuba
Background:
There is increasing evidences that favor the prenatal beginning of schizophrenia. These evidences point toward
intra-uterine environmental factors that act specifically during the second pregnancy trimester producing a direct damage of
the brain of the fetus. The current available technology doesn't allow observing what is happening at cellular level since the
human brain is not exposed to a direct analysis in that stage of the life in subjects at high risk of developing schizophrenia.
Methods:
In 1977 we began a direct electron microscopic research of the brain of fetuses at high risk from schizophrenic
mothers in order to finding differences at cellular level in relation to controls.
Results:
In these studies we have observed within the nuclei of neurons the presence of complete and incomplete viral particles
that reacted in positive form with antibodies to herpes simplex hominis type I [HSV1] virus, and mitochondria alterations.
Conclusion:
The importance of these findings can have practical applications in the prevention of the illness keeping in mind
its direct relation to the aetiology and physiopathology of schizophrenia. A study of the gametes or the amniotic fluid cells in
women at risk of having a schizophrenic offspring is considered. Of being observed the same alterations that those observed
previously in the cells of the brain of the studied foetuses, it would intend to these women in risk of having a schizophrenia
descendant, previous information of the results, the voluntary medical interruption of the pregnancy or an early anti HSV1
viral treatment as preventive measure of the later development of the illness.
segundo@infomed.sld.cuJ Infec Dis Treat 2018, Volume 4
DOI: 10.21767/2472-1093-C1-003




